Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.

Expert opinion on drug metabolism & toxicology - 1 Aug 2016

Jiménez-Jiménez Félix Javier, Alonso-Navarro Hortensia, García-Martín Elena, Agúndez José A G

Abstract excerpt

INTRODUCTION: Several studies suggested a possible association between certain polymorphisms in the N-acetyl-transferase 2 (NAT2) gene (which encodes a very important enzyme involved in xenobiotic metabolism) and the risk for Parkinson's disease (PD). As the results of studies on this issue are controversial, we conducted a systematic review and a meta-analysis of eligible studies on this putative association....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylamine N-Acetyltransferase
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene-Environment Interaction

Share to NAT2 gene

Share to Genetic Predisposition to Disease

Share to Parkinson Disease

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 27216438
DOI: 10.1080/17425255.2016.1192127

Genes

NAT2
GSTM1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.PMID 27216438Read ↗

Variability and validity of polymorphism association studies in Parkinson's disease.Semantic proximity Read ↗

Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.Semantic proximity Read ↗

Glutathione S-transferase T1 and M1 null genotypes and Parkinson's disease risk: evidence from an updated meta-analysis.Semantic proximity Read ↗

CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.Semantic proximity Read ↗

A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism.Semantic proximity Read ↗

NAT2 polymorphism and lung cancer risk: a meta-analysis.Semantic proximity Read ↗

Glutathione S-transferase M1 polymorphisms and Parkinson's disease risk: a meta-analysis.Semantic proximity Read ↗

N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.Semantic proximity Read ↗

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.Semantic proximity Read ↗

The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia.Semantic proximity Read ↗

A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.Semantic proximity Read ↗

Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.